Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Assets Average (2021 - 2025)

Maravai Lifesciences Holdings (MRVI) has 5 years of Assets Average data on record, last reported at $809.9 million in Q4 2025.

  • For Q4 2025, Assets Average fell 29.16% year-over-year to $809.9 million; the TTM value through Dec 2025 reached $809.9 million, down 29.16%, while the annual FY2025 figure was $889.4 million, 28.72% down from the prior year.
  • Assets Average reached $809.9 million in Q4 2025 per MRVI's latest filing, down from $873.1 million in the prior quarter.
  • Across five years, Assets Average topped out at $2.3 billion in Q1 2023 and bottomed at $809.9 million in Q4 2025.
  • Average Assets Average over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2021.
  • Peak YoY movement for Assets Average: skyrocketed 51.06% in 2022, then tumbled 39.94% in 2024.
  • A 5-year view of Assets Average shows it stood at $1.9 billion in 2021, then grew by 18.84% to $2.3 billion in 2022, then fell by 17.13% to $1.9 billion in 2023, then plummeted by 39.11% to $1.1 billion in 2024, then dropped by 29.16% to $809.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $809.9 million in Q4 2025, $873.1 million in Q3 2025, and $928.4 million in Q2 2025.